Triptolide suppresses CD80 and CD86 expressions and IL-12 production in THP-1 cells

Acta Pharmacologica Sinica

Volumn 26, Issue 2, 2005, Pages 223-227

  Liu, Jing ^a   Wu, Qing Li ^a   Feng, Yong Hong ^a   Yang, Yi Fu ^a   Li, Xiao Yu ^a   Zuo, Jian Ping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

CD80 antigens; CD86 antigens; Interleukin 12; Triptolide

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; DITERPENOID; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MACROPHAGE;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELL LINE, TUMOR; DITERPENES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; LEUKEMIA, MYELOID; MEMBRANE GLYCOPROTEINS; MONOCYTES; PHENANTHRENES; PLANTS, MEDICINAL; PROTEIN SUBUNITS; TRIPTERYGIUM;

EID: 13444305372     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00035.x     Document Type: Article

References (30)

1. Schwartz RH. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol 1985; 3: 237-61.
2. Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation. Crit Rev Immunol 1998; 18: 389-418.
3. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225-52.
4. Jonker M, Ossevoort And MA, Vierboom M. Blocking the CD80 and CD86 costimulation molecules: lessons to be learned from animal models. Transplantation 2002; 73: S23-6.
5. Anand S, Chen L. Control of autoimmune diseases by the B7-CD28 family molecules. Curr Pharm Des 2004; 10: 121-8.
6. Gottlieb AB, Lebwohl M, Totoritis MC, Abdulghani AA, Shuey SR, Romano P, et al. Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody. J Am Acad Dermatol 2002; 47: 692-700.
7. Tao XL, Sun Y, Dong Y, Xiao YL, Hu DW, Shi YP, et al. A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis. Chin Med J 1989; 102: 327-32.
8. Lipsky PE, Tao XL. A potential new treatment for rheumatoid arthritis: thunder god vine. Semin Arthritis Rheum 1997; 26: 713-23.
9. Qiu D, Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook f. Drugs R D 2003; 4: 1-18.
10. Su D, Song Y, Li R. Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii. Chin J Integrated Trad West Med 1990; 10: 144-6.
11. Gu WZ, Brandwein SR. Inhibition of type II collagen-induced arthritis in rats by triptolide. Int J Immunopharmacol 1998; 20: 389-400.
12. Li L, Wakukami T, Teng WP, Di GX, Murakami K, Mimura G. The effect of triptolide on the development of insulitis in low-dose streptozotocin induced diabetic mice and on the beta-cells of normal mice. Chin J Diabetes 1994; 2: 69-75.
13. Yi ZW, Li L. Clinical study of nephrotic syndrome in children treated by triptolide. Hunan Med J 1994; 11: 284-5.
14. Lu H, Hachida M, Enosawa S, Li XK, Suzuki S, Koyanagi H. Immunosuppressive effect of triptolide in vitro. Transplant Proc 1999; 31: 2056-7.
15. Chan MA, Kohlmeier JE, Branden M, Jung M, Benedict SH. Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506. Phytother Res 1999; 13: 464-7.
16. Yang Y, Liu Z, Tolosa E, Yang J, Li L. Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology 1998; 40: 139-49.
17. Hong Y, Zhou W, Li K, Sacks SH. Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Kidney Int 2002; 62: 1291-300.
18. Li H, Liu ZH, Dai CS, Liu D, Li LS. Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells. Acta Pharmacol Sin 2002; 23: 775-81.
19. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998; 16: 495-521.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Method 1983; 65: 55-63.
21. Kubin M, Chow JM, Trinchieri G. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 1994; 83: 1847-55.
22. Wu Y, Wang Y, Zhong C, Li Y, Li X, Sun B. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response. Int Immunopharmacol 2003; 3: 1457-65.
23. Lin JF, Zhu H, Liu XQ, Zhen HP, Zheng YL. Triptolide prolong the survival of heart transplant in mice. Strait Pharmacentical J 1998; 10: 29-30.
24. Yang J, Fan Z, Dai C, Wang J, Liu Z, Li L. Antirenal allograft rejection effects of triptolide in rats. J Nephrol Dialy Transplant 1997; 6: 214-20.
25. Chen BJ, Liu C, Cui X, Fidler JM, Chao NJ. Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion. Transplantation 2000; 70: 1442-7.
26. Du ZY, Li XY, Li YC, Wang SY. Analysis of triptolide-regulated gene expression in Jurkat cells by complementary DNA microarray. Acta Pharmacol Sin 2003; 24: 864-72.
27. Monteyne P, Guillaume B, Sindic CJ. B7-1 (CD80), B7-2 (CD86), interleukin-12 and transforming growth factor-beta mRNA expression in CSF and peripheral blood mononuclear cells from multiple sclerosis patients. J Neuroimmunol 1998; 91: 198-203.
28. Liu H, Liu ZH, Chen ZH, Yang JW, Li LS. Triptolide: a potent inhibitor of NF-kappa B in T-lymphocytes. Acta Pharmacol Sin 2000; 21: 782-6.
29. Qiu D, Zhao G, Aoki Y, Shi L, Uyei A, Nazarian S, et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 1999; 274: 13443-50.
30. Caamano J, Hunter CA. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 2002; 15: 414-29.